|
Market Closed -
Nasdaq
00:00:00 12/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 54.21 USD | -2.59% |
|
-6.68% | -31.48% |
| 09-10 | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
| Market Cap | 9.01B 7.76B 7.35B 6.66B 12.5B 861B 12.56B 87.29B 33.57B 438B 33.83B 33.09B 1,384B | P/E 2026 * |
-14.9x | P/E 2027 * | -28.8x |
|---|---|---|---|---|---|
| Enterprise Value | 8.91B 7.67B 7.27B 6.59B 12.35B 851B 12.42B 86.29B 33.18B 433B 33.45B 32.71B 1,368B | EV / Sales 2026 * |
9.76x | EV / Sales 2027 * | 6.57x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
London S.E.
| 0JDI | Delayed | |
|
Tradegate
| ISI | Real-time | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Boerse Muenchen
| ISI | Real-time | |
|
Xetra
| ISI | Delayed |
Last Transcript : Ionis Pharmaceuticals, Inc.
| 1 day | -2.59% | ||
| 1 week | -6.68% | ||
| Current month | -10.19% | ||
| 1 month | -4.10% | ||
| 3 months | -26.02% | ||
| 6 months | -25.06% | ||
| Current year | -31.48% |
| 1 week | 52.15 |  | 57.43 |
| 1 month | 52.15 | | 64.19 |
| Current year | 50 | | 86.74 |
| 1 year | 50 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 31/08/26 | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 31/08/26 | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.59% | -6.68% | -14.17% | +24.59% | 9.01B | |
| -0.71% | -6.35% | -2.99% | +9.59% | 45.48B | |
| +0.21% | -2.98% | +337.74% | +519.55% | 43.68B | |
| +1.74% | -2.24% | +39.82% | +20.76% | 43.09B | |
| +1.38% | -3.28% | +6.84% | +67.62% | 39.4B | |
| -1.44% | -5.26% | +8.97% | +39.76% | 31.91B | |
| +0.87% | -2.60% | - | - | 17.31B | |
| +0.75% | -0.64% | +19.75% | +110.17% | 16.4B | |
| -0.31% | -2.78% | +10.78% | +31.02% | 14.24B | |
| +1.93% | -3.55% | +82.00% | +41.17% | 13.28B | |
| Average | +0.18% | -3.88% | +54.30% | +96.03% | 27.38B | |
| Weighted average by Cap. | +0.31% | -3.77% | +71.45% | +120.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 913M 786M 745M 675M 1.27B 87.2B 1.27B 8.84B 3.4B 44.36B 3.43B 3.35B 140B | 1.38B 1.19B 1.13B 1.02B 1.92B 132B 1.93B 13.39B 5.15B 67.18B 5.19B 5.08B 212B |
| Net income | -584M -503M -476M -432M -810M -55.77B -814M -5.66B -2.17B -28.37B -2.19B -2.14B -89.65B | -314M -271M -256M -232M -436M -30.03B -438M -3.05B -1.17B -15.28B -1.18B -1.15B -48.28B |
| Net Debt | -103M -88.74M -84.02M -76.16M -143M -9.84B -144M -998M -384M -5.01B -387M -378M -15.82B | 68.31M 58.85M 55.73M 50.51M 94.76M 6.53B 95.24M 662M 255M 3.32B 257M 251M 10.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | $54.21 | -2.59% | 2,175,778 |
| 10/09/26 | $55.65 | -0.66% | 3,057,309 |
| 09/09/26 | $56.02 | -1.22% | 3,037,757 |
| 08/09/26 | $56.71 | -2.38% | 9,175,745 |
| 04/09/26 | $58.09 | -0.07% | 2,671,092 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
